A B S T R A C T The acute effects of epinephrine, norepinephrine, and isoproterenol on the plasma immunoreactive parathyroid hormone (iPTH) response were studied in 13 550-600 kg cows. Catecholamines were infused for 7.0 min. During epinephrine infusions at 0.08 Amol/min iPTH increased from 0.48±0.12 (mean+SE, ng/ml) to 1.09±0.18 ng/ml (P < 0.02). Small increases in plasma free fatty acids and glucose could be detected with 0.08 Amol/min epinephrine; the iPTH response to epinephrine was as sensitive as the free fatty acid and glucose responses and possibly of physiological importance. Plasma calcium (total and ionized) and magnesium did not change.
A B S T R A C T The acute effects of epinephrine, norepinephrine, and isoproterenol on the plasma immunoreactive parathyroid hormone (iPTH) response were studied in 13 550-600 kg cows. Catecholamines were infused for 7.0 min. During epinephrine infusions at 0.08 Amol/min iPTH increased from 0.48±0.12 (mean+SE, ng/ml) to 1.09±0.18 ng/ml (P < 0.02). Small increases in plasma free fatty acids and glucose could be detected with 0.08 Amol/min epinephrine; the iPTH response to epinephrine was as sensitive as the free fatty acid and glucose responses and possibly of physiological importance. Plasma calcium (total and ionized) and magnesium did not change.
The responses were more pronounced at 0.8 /mol/min epinephrine with a mean iPTH increase from 0.49±0.16 ng/ml to 1.74±0.35 ng/ml (P < 0.01). Small decreases in plasma calcium occurred at 0.8 Amol/min epinephrine, but the plasma magnesium remained unchanged. However, when the plasma calcium was lowered with ethylene glycol bis (3-aminoethyl ether) -N, N'-tetraacetic acid (EGTA), a much more pronounced lowering of the plasma calcium was required to produce comparable increases of the plasma iPTH concentrations than when epinephrine was infused. It appears that epinephrine has a direct effect on the release of iPTH from the parathyroid glands.
Simultaneous infusions of calcium and epinephrine suppressed the stimulation by epinephrine. This points towards a common mechanism of the regulation of parathyroid hormone secretion caused by decreases in the extracellular calcium concentration and/or alterations in
INTRODUCTION
The most important factors regulating parathyroid hormone (PTH)' secretion are the plasma calcium and magnesium concentrations. There is an inverse relationship between the responses of immunoreactive parathyroid hormone (iPTH) and changes in plasma calcium and magnesium (1) (2) (3) (4) (5) . A decrease in the plasma ionized calcium concentration (Ca"+) rather than a fall in plasma total calcium (Ca) is responsible for the acute iPTH response in the cow in vivo (5) .
There is evidence from the study of parathyroid explants in vitro that the addition of catecholamines, dibutyryl cyclic adenosine 3',5'-monophosphate (cyclic AMP), and thyrocalcitonin to the incubation medium stimulates PTH secretion (6) (7) (8) (9) 16 min after the start of the infusions. When the effects of epinephrine were compared with epinephrine-plus-calcium and epinephrine-plus-propranolol, epinephrine was infused from time "0" to 7.0 min and from 60.0 to 67.0 min.
Propranolol or calcium was infused through a second catheter driven by a second identical peristaltic pump. Propranolol dissolved in 0.9% NaCl was infused at 70 ,umol/min from 56.0 to 68.0 min. Calcium was infused as 10% calciumborogluconate at 6.7 mmol/min from 38.0 to 45.0 min and at 2.0 mmol/min for the remainder of the experiments.
Results were either expressed as mean values (with SEM) or as the mean of the incremental or decremental (A) changes of samples taken at 6, 7, and 8 min after the start of the epinephrine infusions (6-8' A).
Before and during the infusion with catecholamines the heart rate was estimated at 1-2 min time intervals.
Materials. Isoproterenol HC1 was obtained from Winthrop Products Co., Surbiton-on-Thames, England, and propranolol was a gift from Imperial Chemical Industries, Macclesfield, England. Epinephrine and norepinephrine were purchased from Fluka AG, Buchs, Switzerland, and EGTA was purchased from the City Chemical Corp., New York.
Methods of analysis. Immunoreactive parathyroid hormone was determined in multiple dilutions in plasma by radioimmunoassay according to Arnaud, Tsao, and Littledike (15) . The following alterations were made: Highly purified 1-84 amino acid bovine PTH extracted from parathyroid glands (Wilson Laboratories, Chicago, Ill.; Lot 147865) was used for iodination wvith 13"I (The Radiochemi- plasma and 1-84 bovine PTH were practically superimposable indicating immunological similarity (16) . Furthermore, the affinity of chicken 14 M anti-bovine PTH serum for synthetic 1-34 bovine PTH (17) (Beckman Instruments, Inc., Palo Alto, Calif.) is practically identical (on the basis of protein) to its affinity for 1-84 bovine PTH extracted from bovine parathyroid glands. This suggests that this antiserum reacts well with the biologically active region of the PTH molecule (amino terminal).' All samples from one experiment were analyzed in the same assay. The coefficient of variation of a measurement within the same assay was 12% and between assays 14%o.
Calcium was determined by automatic EGTA titration using calcein as an indicator (Marius Calcium Titrator, Utrecht, The Netherlands) (coefficient of variation 0.8%). (coefficient of variation 0.7%) (13, 14) . Changes in pH in response to the various infusions did not exceed 0.06 units; the mean changes were 0.00 (SEM 0.004) (n = 58) and therefore did not affect the changes in Ca"". Magnesium was measured by atomic absorption flame spectrophotometry (Perkin-Elmer Corp., Norwalk, Conn.; Model 305) (coefficient of variation 1.3%o). Glucose was measured by an oxidase method (coefficient of variation 1.1%) (18) , and the free fatty acid concentrations were assayed by a colorimetric technique (coefficient of variation 5.0%) (19) .
Statistical analysis was done by paired t test and by regression analysis (20) .
RESULTS
The acute immunoreactive parathyroid hormone response to epinephrine. Epinephrine was infused for 7.0 min, and it briskly increased the concentration of iPTH in the plasma with peak values occurring between 4 and 8 min (Fig. 1) . iPTH responses were compared to the known effects of epinephrine on free fatty acid and glucose release. For this purpose epinephrine was infused at a relatively low dose of 0.08 /smol/min into six cows.
iPTH and free fatty acids increased significantly during the infusions (P < 0.05), whereas no significant increase in plasma glucose levels could be detected until after the end of the epinephrine infusions. The heart rate did not change. Plasma Ca and Mg concentrations remained unchanged.
In contrast, when on a different day 0.8 imol/min epinephrine was infused into the same animals the iPTH response was more pronounced together with a delayed but significant (P < 0.001) increase Mg fusion of 2.0 mmol/min for the remainder of the experiment. Plasma Ca was raised significantly from 9.97±0.27 (mean+SE, mg/100 ml) to 12.21±0.59 mg/100 ml (P < 0.02) and the plasma Ca'+ from 4.38+0.23 to 5.42±0.34 mg/100 ml (P < 0.01). As a consequence the plasma iPTH was decreased but not significantly (P < 0.1). When epinephrine was infused from 60.0 to 67.0 min in the presence of a raised plasma Ca, iPTH did not change. The difference of the epinephrine response (mean 6-8'A) in the absence and in the presence of a raised plasma Ca level was significant (P < 0.05). The plasma Mg did not change.
When propranolol was infused at 70 gmol/min, the iPTH at 60 min was decreased but not significantly (P < 0.2). In the presence of epinephrine there was a small increase in iPTH of 0.12±0.04 ng/ml, which contrasted with a larger increase of 1.23±0.27 ng/ml (mean 6-8'A) in the absence of propranolol. The difference of the iPTH response was significant (P < 0.025).
The acute immunoreactive parathyroid hormone response to isoproterenol and norepinephrine. At 0.08 Amol/min isoproterenol was inactive, but at 0.8 /Amol/ min the iPTH levels increased significantly (P < 0.01) ( (17) suggests that the secretion of PTH is increased. However, because the measurements have not been performed in the venous effluent of the parathyroid glands but in peripheral plasma samples, a metabolic alteration of the circulating iPTH peptides cannot be ruled out.
The increase in iPTH was demonstrated at a dose level of epinephrine (0.08 Amol/min) that enhanced the release of free fatty acids and of glucose only slightly (21) . The heart rate did not change; it appears unlikely that hemodynamic alterations affected the iPTH response to epinephrine at the relatively low dose used. The plasma Ca (and Ca++) and Mg did not change. When higher amounts of epinephrine (0.8 /mol/ mim) were infused the iPTH response was more pronounced, and it was followed by a delayed and marked rise in free fatty acids and glucose and a moderate rise in the heart rate. There were small decreases of the plasma ionized and total calcium and no changes of the plasma magnesium concentrations. More important, however, is the demonstration that decreases of plasma Ca (and Ca++) produced by epinephrine infusions increased iPTH much more than comparable decreases of plasma calcium produced by EGTA. In addition to inducing small decreases in the plasma calcium concentrations, epinephrine appears to be able to raise iPTH directly. This is supported by the stimulation of the iPTH secretion with epinephrine seen in vitro in parathyroid explant cultures (6, 7).
The presence of a rich adrenergic nerve supply to the parathyroid glands (22, 23) suggests a possible role for the autonomic nervous system in the physiological regulation of PTH secretion. A direct neural mechanism has been demonstrated for the beta adrenergic-mediated control of glucagon secretion (24) . The existence of a similar mechanism in parathyroid glands is possible because iPTH responses to epinephrine can occur without marked decreases of the plasma ionized and total calcium and no changes of the plasma magnesium concentrations.
Epinephrine was more active on a molar basis than isoproterenol in sharply raising iPTH in vivo, and norepinephrine was the least active. The stimulation by the beta specific agent isoproterenol and the suppression of the iPTH response to epinephrine by the betablocking agent propranolol suggest a beta adrenergic receptor site within parathyroid glands.
The action of beta adrenergic agents are probably mediated by increases in cyclic AMP. Ball et al. (12) have demonstrated that plasma cyclic AMP increased in response to infusions with epinephrine, isoproterenol, or norepinephrine, but no increase occurred in the presence of propranolol. These observations are consistent with the concept that the action of beta adrenergic agents are mediated by increases in cyclic AMP in target tissues. This is supported by the results obtained in vitro by Abe and Sherwood (8, 25) (26) . It points towards a common mechanism of the stimulation of PTH secretion caused by decreases in extracellular calcium concentration and/or by epinephrine and of the suppression of PTH secretion with calcium.
The recent description of a 12 yr old boy with familial pheochromocytoma and mild hypercalcemia, whose serum calcium returned to normal levels after adrenalectomy suggests that he might temporarily have suffered from a new form of secondary hypercalcemic hyperparathyroidism caused by the raised epinephrine levels in the blood. The possibility that the pheochromocytoma of this patient secreted a substance with PTH-like activity cannot, of course, be ruled out (27 
